ArticleBMJ (Clinical research ed.)1998
Cost effectiveness of shortening screening interval or extending age range of NHS breast screening programme: computer simulation study.
Article in BMJ (Clinical research ed.), 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Cost effectiveness of breast cancer screening and prevention: a systematic review with a focus on risk-adapted strategies.The European journal of health economics : HEPAC : health economics in prevention and care · 2021Pooled it
- Evaluation of optimal strategies for breast cancer screening in Ghana: A simulation study based on a continuous tumor growth model.PloS one · 2025Article
- The financial cost of preventive and curative programs for breast cancer: a case study of women in Shiraz-Iran.International journal of health policy and management · 2014Article
- Cost-effectiveness of health-related lifestyle advice delivered by peer or lay advisors: synthesis of evidence from a systematic review.Cost effectiveness and resource allocation : C/E · 2013Article
- Cost effectiveness of the NHS breast screening programme: life table model.BMJ (Clinical research ed.) · 2013Article
- Cost effectiveness of breast cancer screening using mammography; a systematic review.Iranian journal of public health · 2013Article
- Prediction of higher mortality reduction for the UK Breast Screening Frequency Trial: a model-based approach on screening intervals.British journal of cancer · 2011Article
- Tumour doubling times and the length bias in breast cancer screening programmes.Health care management science · 2011Article
- Cost-effectiveness analysis of mammography and clinical breast examination strategies: a comparison with current guidelines.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2009Article
- Calibration methods used in cancer simulation models and suggested reporting guidelines.PharmacoEconomics · 2009Review
- Impact of UK policy initiatives on use of medicines to aid smoking cessation.Tobacco control · 2005Article
- Breast cancer screening services: trade-offs in quality, capacity, outreach, and centralization.Health care management science · 2004Article
- Cost-effectiveness of stereotactic large-core needle biopsy for nonpalpable breast lesions compared to open-breast biopsy.British journal of cancer · 2004Article
- Interval cancers in the Dutch breast cancer screening programme.British journal of cancer · 1999Article
- Universal HIV screening of pregnant women in England: cost effectiveness analysis.BMJ (Clinical research ed.) · 1999Article
- NHS breast screening programme. Both extended age range and reduced screening interval are needed.BMJ (Clinical research ed.) · 1999Article
- Extending the benefits of breast cancer screening. Still hard to know how large the benefits will really be.BMJ (Clinical research ed.) · 1998Article
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Commented on by
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo compare the cost effectiveness of two possible modifications to the current UK screening programme: shortening the screening interval from three to two years and extending the age of invitation to a final screen from 64 to 69.
designComputer simulation model which first simulates life histories for women in the absence of a screening programme for breast cancer and then assesses how these life histories would be changed by introducing different screening policies. The model was informed by screening and cost data from the NHS breast screening programme.
settingNorth West region of England.
main outcome measuresNumbers of deaths prevented, life years gained, and costs.
resultsCompared with the current breast screening programme both modifications would increase the number of deaths prevented and the number of life years saved. The current screening policy costs 2522 pounds per life year gained; extending the age range of the programme would cost 2612 pounds and shortening the interval 2709 pounds per life year gained. The marginal cost per life year gained of extending the age range of the screening programme is 2990 pounds and of shortening the screening interval is 3545 pounds.
conclusionsIf the budget for the NHS breast screening programme were to allow for two more invitations per woman, substantial mortality reductions would follow from extending the age range screened or reducing the screening interval. The difference between the two policies is so small that either could be chosen.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.